said Monday that the Food and Drug Administration approved its intravenous drug to reduce blood pressure. Shares were climbing 86 cents, or 3.8%, at $23.46 in recent trading Monday morning. Cleviprex ...

The Medicines Company announced launch of a new twelve hour formulation for Cleviprex (clevidipine) injectable emulsion, which was approved by the US Food and Drug Administration (US FDA) in June 2011 ...

The FDA has approved Cleviprex (clevidipine butyrate, from The Medicines Company), an IV calcium channel blocker, for the reduction of blood pressure when oral therapy is not feasible or desirable.

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced that ECLIPSE, the largest safety program to date comparing intravenous antihypertensive therapies, has been ...

Cleviprex injection recalled due to presence of particulate matter The FDA and The Medicines Company have notified healthcare professionals of a voluntary nationwide recall of 11 lots of Cleviprex ...

The Medicines Company announced that it is voluntarily expanding the recall of Cleviprex (clevidipine butyrate) injectable emulsion due to the potential presence of visible particulate matter which ...

The Medicines Company today announced that the U.S. Food and Drug Administration has accepted the Parsippany-based pharmaceutical company’s new drug application for Cleviprex for the treatment of ...

WASHINGTON (AP) — Federal health regulators are warning doctors about 11 recalled lots of an intravenous hypertension drug made by the Medicines Co. that are contaminated with bits of steel. The ...

DUBLIN--(BUSINESS WIRE)--The "Cleviprex 2017 U.S. Promotional Audit Report" report has been added to ResearchAndMarkets.com's offering. The 5 Key Questions Addressed by this Report: How many ...

The Medicines Co. has received U.S. approval of its intravenous drug for high blood pressure, Cleviprex, the first new I.V. antihypertensive to come on the market in 10 years. The Parsippany, ...

FOR IMMEDIATE RELEASE - March 17, 2010 - Parsippany, N.J. - The Medicines Company (NASDAQ: MDCO) announced today that it is voluntarily expanding the recall of Cleviprex ® (clevidipine butyrate) ...